Pseudomonas aeruginosa

Résumé

Pseudomonas aeruginosa, autrement connu sous le nom de bacille pyocyanique, bacille du pus bleu ou pyo, est une bactérie gram-négative du genre Pseudomonas. Les bacilles sont fins, droits et très mobiles grâce à un flagelle polaire : ciliature monotriche, dépourvus de spores et de capsules. Ils apparaissent la plupart du temps isolés ou en diplobacilles. Elle peut, dans certaines conditions, être pathogène. Très résistante, elle est — avec d'autres bactéries à gram-négatif — de plus en plus souvent responsable d'infections nosocomiales. C'est l'une des bactéries les plus difficiles à traiter cliniquement. Le taux de mortalité atteint 50 % chez les patients vulnérables (immunodéprimés). Germe ubiquitaire, vivant dans les sols et en milieu humide (nuages, robinets, bouchons), très résistant à de nombreux antiseptiques, fréquent en milieu hospitalier, entraînant l'apparition (du fait de sa résistance aux antibiotiques) de véritables souches d'hôpital. Elle peut survivre dans de l'eau di

Source officielle

https://fr.wikipedia.org/wiki/Pseudomonas_aeruginosa

À propos de ce résultat

Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.

Publications associées (36)

Publications associées

Chargement

Personnes associées (4)

Personnes associées

Chargement

Unités associées (5)

Unités associées

Chargement

Concepts associés (69)

Concepts associés

Chargement

Cours associés (11)

Cours associés

Chargement

Séances de cours associées (17)

Afficher plus

Séances de cours associées

Chargement

EPFL2003

Chargement

Design and Evaluation of New Quinazolin-4(3H)-one Derived PqsR Antagonists as Quorum Sensing Quenchers in Pseudomonas aeruginosa

Eduard Vico Oton

P. aeruginosa (PA) continues to pose a threat to global public health due to its high levels of antimicrobial resistance (AMR). The ongoing AMR crisis has led to an alarming shortage of effective treatments for resistant microbes, and hence there is a pressing demand for the development of novel antimicrobial interventions. The potential use of antivirulence therapeutics to tackle bacterial infections has attracted considerable attention over the past decades as they hamper the pathogenicity of target microbes with reduced selective pressure, minimizing the emergence of resistance. One such approach is to interfere with the PA pqs quorum sensing system which upon the interaction of PqsR, a Lys-R type transcriptional regulator, with its cognate signal molecules 4-hydroxy-2-heptylquinoline (HHQ) and 2-heptyl-3-hydroxy-4-quinolone (PQS), governs multiple virulence traits and host-microbe interactions. In this study, we report the hit identification and optimization of PqsR antagonists using virtual screening coupled with whole cell assay validation. The optimized hit compound 61 ((R)-2-(4-(3-(6-chloro-4-oxoquinazolin-3(4H)-yl)-2-hydroxypropoxy)phenyl)acetonitrile) was found to inhibit the expression of the PA P-pqsA promoter controlled by PqsR with an IC50 of 1 mu M. Using isothermal titration calorimetry, a K-d of 10 nM for the P-qsR ligand binding domain (PqsR(LBD)) was determined for 61. Furthermore, the crystal structure of 61 with PqsR(LBD) was attained with a resolution of 2.65 angstrom. Compound 61 significantly reduced levels of pyocyanin, PQS, and HHQ in PAO1-L, PA14 lab strains and PAK6085 clinical isolate. Furthermore, this compound potentiated the effect of ciprofloxacin in early stages of biofilm treatment and in Galleria mellonella infected with PA. Altogether, this data shows 61 as a potent PqsR inhibitor with potential for hit to lead optimization toward the identification of a PA QS inhibitor which can be advanced into preclinical development.

AMER CHEMICAL SOC2021

Chargement

Pseudomonas aeruginosa pneumonia is a life threatening complication in mechanically ventilated patients that requires the ability of the bacteria to adhere to, and colonize the endotracheal intubation device. New strategies to prevent or reduce these nosocomial infections are greatly needed. We report here the study of a set of P. aeruginosa clinical isolates, together with specific mutants, regarding their adhesion on native and chemically modified poly(vinyl chloride) (PVC) surfaces from endotracheal intubation devices. The adhesion of the different strains to untreated PVC varied widely, correlating with several physico-chemical characteristics known to influence the attachment of bacteria to inert surfaces. The adhesion patterns were compared to the calculations obtained with the DLVO theory of colloidal stability. These results illustrate the importance of testing different clinical isolates when investigating bacterial adhesion. Oxygen plasma treatment of the PVC pieces yielded a hydrophilic surface and reduced the number of adhering bacteria by as much as 70%. This reduction is however unlikely to be sufficient to prevent P. aeruginosa colonization of endotracheal intubation devices. (C) 2002 Elsevier Science Ltd. All rights reserved.

2003

Chargement

Design and Evaluation of New Quinazolin-4(3H)-one Derived PqsR Antagonists as Quorum Sensing Quenchers in Pseudomonas aeruginosa

Eduard Vico Oton

AMER CHEMICAL SOC2021